Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Albutamol Neo
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Albutamol Neo is an oral fixed-dose combination bronchodilator therapy developed by Centaur Pharmaceuticals for the management of respiratory conditions, including asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). Formulated as a syrup, it combines salbutamol, a selective beta-2 adrenergic receptor agonist, with etofylline, a xanthine derivative that acts as a phosphodiesterase inhibitor and adenosine receptor antagonist. Together, these active ingredients work synergistically to relax bronchial smooth muscle, widen the airways, and improve airflow, thereby relieving symptoms such as wheezing, chest tightness, and shortness of breath.
- Brand names
- Albutamol NeoAlbutamol Neo Syrup
- Other names
- etofylline + salbutamolsalbutamol + etofylline
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)PDE4 (Phosphodiesterase 4A1)ADRB2 (β2)
Beyond the preview
Go deeper on Albutamol Neo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Albutamol Neo.